曼恩凯德生物医疗 MNKD 深 沪
交易中 05-18 11:12:00 美东时间
3.035
-0.055
-1.78%
华盛通- 最 高3.17
- 今 开3.13
- 成交量 102.68万股
- 最 低 3.02
- 昨 收 3.09
- 总市值 9.38亿
- 52周最高 6.51
- 市盈率 静 162.30
- 换手率 0.33%
- 52周最低 2.23
- 委 比 13.77%
- 总股本 3.09亿
- 历史最高 57.40
- 量 比 0.89
- 振 幅 4.85%
- 历史最低 0.666
- 每 手 1
- 风险率 1.16%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MannKind director Steven B. Binder disposes of 22,500 shares worth $75,927.40
MannKind director Steven B. Binder disposes of 22,500 shares worth $75,927.40 Steven B. Binder, director, cut stake in MannKind to 808,008 common shares following transactions dated May 11-12. Disposed of 16,940 shares at USD 3.29 under a Rule 10b5-1 plan. Withheld 5,560 shares at USD 3.52 to cover
05-14 08:30
美股大行评级 | 绩后暴跌10%，ARM仍获高盛、富国银行等多家大行上调目标价；康宁、优步、飞塔信息、西维斯、Agilon Health等获多家大行上调目标价
今日重点评级关注：Citizens：维持BioCryst制药"跑赢大市"评级，目标价从25美元升至28美元；富国银行：维持曼恩凯德生物医疗"超配"评级，目标价从8美元升至10美元
05-08 12:05
MannKind Leans Into Growth Amid Earnings Volatility
MannKind Corporation (($MNKD)) has held its Q1 earnings call. Read on for the m...
05-08 10:17
Mizuho Maintains Outperform on MannKind, Lowers Price Target to $7
Mizuho analyst Anthony Petrone maintains MannKind (NASDAQ:MNKD) with a Outperform and lowers the price target from $8 to $7.
05-07 20:39
电话会总结 ｜ MannKind(MNKD)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据MannKind业绩会实录，以下是2026年第一季度财务业绩回顾摘要： ## 1. 财务业绩 **总体营收表现：** - 总营收达到9000万美元，同比增长15%，主要受益于FURO6产品的贡献 **各产品线营收情况：** - FURO6净销售额：1550万美元，剂量分发量同比增长64%，IDN业务同比增长97% - Afrezza净销售额：1530万美元，同比增长3% - Tyvaso DPI合作服务收入：2350万美元，较去年同期的2940万美元下降590万美元 - 特许权使用费收入：3270万美元，同比增长9% **盈利能力：** - GA
05-07 12:27
美股夜盘 | Fluence Energy, Inc. Class A涨25.88%，SiTime Corporation涨24.31%
Fluence Energy, Inc. Class A涨25.88%；SiTime Corporation涨24.31%；飞塔信息涨15.06%
05-07 10:01
美股夜盘 | Fluence Energy, Inc. Class A涨25.44%，SiTime Corporation涨21.12%
Fluence Energy, Inc. Class A涨25.44%；SiTime Corporation涨21.12%；库力索法半导体涨17.58%
05-07 09:01
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
MannKind Q1 Adj. EPS $(0.02) Misses $(0.00) Estimate, Sales $90.171M Miss $106.555M Estimate
MannKind (NASDAQ:MNKD) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.00) by Infinity percent. This is a 128.57 percent decrease over earnings of $0.07 per share from
05-07 04:08
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers GlucoTrack (NASDAQ:GCTK) stock increased by 39.7% to $1.02 during Wedn...
05-07 01:05
